Delivery Order SPE2DX15D6028-SPE2DX24FWEBC

Award Date 10/11/23
Potential Completion Date 11/7/23
Potential Value $13K
Federal Agency
Medical Supply Chain
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is from the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, with a ceiling value of $3,993.80, is for the delivery of MULTIHANCE 529MG/ML 5S, a medical product. The contract has an ultimate completion date of March 29, 2024 and was awarded on March 4, 2024. This contract is a delivery order under a larger Indefinite Delivery Contract (IDC) that...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The award is for the delivery of MULTIHANCE 529 MG/ML VIAL 20ML, a medical supply item. The contract has a ceiling value of $3,746.05 and is a firm fixed-price delivery order with a completion date of June 10, 2025. The contract is not set-aside and is open to full and open competition. Amerisourcebergen Drug Corp is the...
This federal contract award is for the supply of MULTIHANCE 529 MG/ML VIAL 20ML, a pharmaceutical product, to the Defense Logistics Agency (DLA). The $5,989.50 firm-fixed-price delivery order was issued to the prime contractor, Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical, which serves to provide a wide range of pharmaceutical...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract has an award value of $5,792.88 and is a delivery order contract for the supply of a pharmaceutical product, MULTIHANCE 529MG/ML 5S. The contract has a period of performance through March 6, 2025 and is a firm fixed price contract. This award is associated with a larger Indefinite...
This federal contract award, with ID SPE2DX15D3012|SPE2DX24F8VM4, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of MULTIHANCE 529 MG/ML VIAL 15ML, a medical supply product. The award has a ceiling value of $1,397.29 and a completion date of September 20, 2024. This contract is not designated as a set-aside. Amerisourcebergen Drug Corp's Corporate Office Division holds...
This federal contract award, with a GovTribe ID of SPE2DX15D6028|SPE2DX25FWLUQ, was issued by the Defense Logistics Agency's Medical Supply Chain division to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $4,680.18 firm-fixed-price delivery order is for the supply of MULTIHANCE 529MG/ML 5S, a pharmaceutical product. The contract has an ultimate completion date of June 10, 2025 and does not utilize any set-aside designations. Amerisourcebergen Drug Corp holds a larger...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The $5,733.00 firm fixed price delivery order is for the supply of MULTIHANCE 529 MG/ML VIAL 20ML, a pharmaceutical product. The contract has a completion date of January 30, 2024 and was awarded on January 29, 2024. Amerisourcebergen Drug Corp is the prime contractor...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract is for the delivery of MULTIHANCE 529 MG/ML VIAL 20ML, a pharmaceutical product, with a potential value of $1,719.90 and a completion date of January 9, 2024. Amerisourcebergen Drug Corp, a for-profit organization, has a history of providing pharmaceutical products and medical supplies to...
This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the delivery of PROHANCE 279.3 MG/ML VIAL 20ML medical supplies. The contract has a ceiling value of $3,840.40 and an ultimate completion date of November 27, 2024. It was awarded by the Defense Logistics Agency (DLA) Troop Support Medical, a component of the Department of Defense, as a delivery order contract with a firm fixed price pricing type. The award...
This federal contract award was issued by the Medical Supply Chain, an organization within the Defense Logistics Agency (DLA), to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,391.85, is a Firm Fixed Price Delivery Order for the procurement of PROHANCE 279.3 MG/ML VIAL 20ML, a pharmaceutical product. The contract has an ultimate completion date of May 23, 2024. AmerisourceBergen holds a significant Indefinite...
  • SPE2DX15D6028
    Indefinite Delivery Contract
  • SPE2DX15D6028-SPE2DX24FWEBC
    Delivery Order

This federal contract award is for the delivery of MULTIHANCE 529MG/ML 5S medical supplies from the prime contractor, Amerisourcebergen Drug Corp, to the Defense Logistics Agency (DLA) Troop Support Medical. The contract has a ceiling value of $13,382.60 and an ultimate completion date of November 7, 2023. The contract is a Delivery Order placed under an Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract award does not have a set-aside designation, indicating open competition.

Generated 5/14/25, 9:50 AM